1Forrester JV, Dick AD, Mcmenamin PG, et al. The eye basic science in practice[M]. 2nd. Philadelphia : Elsevier Science, 2013:228-229.
2Pearce E, Sivaprasad S, Chong NV. Comparing fixation location and stability in patients with neovascular age-related macular degeneration treated with or without Ranibizumab[J]. Eye , 2011, 25(2):149-153.
3Schmidt-Erfurth U, Eldem B, Guymer R, et al. Efficacy and safety of monthly versus quarterly ranihizumah treatment in neovascular age-related macular degeneration: the EXCITE study[J]. Ophthalmology, 2011, 1 l 8(5):831-839.
4Markowitz SN, Reyes SV. Microperimetry and clinical practice: an evidence- based review[J]. Can J Ophthalmol,2013,48(5): 350-357.
同被引文献5
1Kaufman PL, Aim A. Adler's Physiology of the Eye[M].11th ed. St. Louis: Mosby, 2011: .531-541.
